<DOC>
	<DOCNO>NCT02305862</DOCNO>
	<brief_summary>The aim study ass whether high intensive statin therapy could regress carotid atherosclerotic plaque determine High-Resolution Contrast Enhanced Magnetic Resonance imaging ( CE-MRI ) . Enrolled patient baseline CE-MRI examination screen carotid atherosclerotic plaque randomize either low dose Rosuvastatin ( 5mg ) group high dose Rosuvastatin ( 20mg ) group . After 26 week , patient receive CE-MRI examination pair baseline follow-up CE-MRI assessment analyze blinded fashion . Moreover , lipid level major adverse cardiovascular event also evaluate follow-up .</brief_summary>
	<brief_title>A High-Resolution Magnetic Resonance Imaging Study Evaluate Effect Rosuvastatin Carotid Atherosclerotic Plaques</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Plaque , Atherosclerotic</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Patients coronary artery disease carotid atherosclerotic plaque hyperlipideimia old myocardial infarction Planning coronary stenting Heart failure Uncontrolled hypertension（≥200/110mmHg ) Uncontrolled diabetes mellitus ( HbA1C≥9.5 % ) Hepatic insufficiency Renal dysfunction Cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Coronary Arteriosclerosis</keyword>
	<keyword>Carotid Atherosclerotic Plaque</keyword>
	<keyword>Rosuvastatin</keyword>
</DOC>